Literature DB >> 3415870

Neuroendocrine activation after acute myocardial infarction.

H M McAlpine1, J J Morton, B Leckie, A Rumley, G Gillen, H J Dargie.   

Abstract

The extent of neuroendocrine activation, its time course, and relation to left ventricular dysfunction and arrhythmias were investigated in 78 consecutive patients with suspected acute myocardial infarction. High concentrations of arginine vasopressin were found within six hours of symptoms, even in the absence of myocardial infarction (n = 18). Plasma catecholamine concentrations also were highest on admission, whereas renin and angiotensin II concentrations rose progressively over the first three days, not only in those with heart failure but also in patients with no clinical complications. Heart failure, ventricular tachycardia, and deaths were associated with extensive myocardial infarction, low left ventricular ejection fraction, and persistently high concentrations of catecholamines, renin, and angiotensin II up to 10 days after admission, whereas in uncomplicated cases concentrations had already returned to normal.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415870      PMCID: PMC1216532          DOI: 10.1136/hrt.60.2.117

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  38 in total

1.  The adrenal function in coronary thrombosis.

Authors:  O FORSSMAN; G HANSSON; C JENSEN
Journal:  Acta Med Scand       Date:  1952-04-30

2.  Concentration-dependent protection by captopril against myocardial damage during ischemia and reperfusion in a closed chest pig model.

Authors:  P A de Graeff; W H van Gilst; K Bel; C D de Langen; J H Kingma; H Wesseling
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

3.  Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart-failure in patients with acute myocardial infarction.

Authors:  D E Jewitt; D Reid; M Thomas; C J Mercer; C Valori; J P Shillingford
Journal:  Lancet       Date:  1969-03-29       Impact factor: 79.321

4.  Plasma-catecholamines after cardiac infarction.

Authors:  L McDonald; C Baker; C Bray; A McDonald; N Restieaux
Journal:  Lancet       Date:  1969-11-15       Impact factor: 79.321

Review 5.  Control of renin release.

Authors:  A J Vander
Journal:  Physiol Rev       Date:  1967-07       Impact factor: 37.312

6.  Serum cortisol, plasma free fatty acids, and urinary cathecholamines as indicators of complications in acute myocardial infarction.

Authors:  R Prakash; W W Parmley; M Horvat; H J Swan
Journal:  Circulation       Date:  1972-04       Impact factor: 29.690

7.  Pitressin-induced myocardial injury and depression in a young woman.

Authors:  B M Beller; A Trevino; E Urban
Journal:  Am J Med       Date:  1971-11       Impact factor: 4.965

8.  Inhibition of renin release in the dog by vasopressin and vasotocin.

Authors:  A J Vander
Journal:  Circ Res       Date:  1968-11       Impact factor: 17.367

9.  Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man.

Authors:  H Gavras; D Kremer; J J Brown; B Gray; A F Lever; R F MacAdam; A medina; J J Morton; J I Robertson
Journal:  Am Heart J       Date:  1975-03       Impact factor: 4.749

10.  Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction.

Authors:  C Valori; M Thomas; J Shillingford
Journal:  Am J Cardiol       Date:  1967-11       Impact factor: 2.778

View more
  29 in total

Review 1.  Postinfarction left ventricular remodelling: where are the theories and trials leading us?

Authors:  Z R Yousef; S R Redwood; M S Marber
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

2.  Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model.

Authors:  D L Jardine; C J Charles; R K Ashton; S I Bennett; M Whitehead; C M Frampton; M G Nicholls
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

Review 3.  Angiotensin converting enzyme inhibitors for hypertension and heart failure?

Authors:  J G Cleland
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

Review 4.  Vascular tone in heart failure: the neuroendocrine-therapeutic interface.

Authors:  J G Cleland; C M Oakley
Journal:  Br Heart J       Date:  1991-10

Review 5.  The renin-angiotensin-aldosterone system and cardiac ischaemia.

Authors:  H Ikram
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 6.  Activated tissue renin-angiotensin systems add to the progression of heart failure.

Authors:  Y M Pinto; H Buikema; W H van Gilst; K I Lie
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

7.  Oleuropein attenuates the progression of heart failure in rats by antioxidant and antiinflammatory effects.

Authors:  Zeinab Janahmadi; Ali Akbar Nekooeian; Ali Reza Moaref; Masoomeh Emamghoreishi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-08       Impact factor: 3.000

8.  Effect on coronary artery flow reserve and resistance in the remote area after acute coronary artery occlusion in the pig model.

Authors:  F Haas; N Nguyen; H Schad; W Heimisch; C Haehnel; G Weigand; W Ehrhard; H Meisner; M Schwaiger
Journal:  J Nucl Cardiol       Date:  1999 Sep-Oct       Impact factor: 5.952

9.  Early treatment with captopril after acute myocardial infarction.

Authors:  S G Ray; M Pye; K G Oldroyd; J Christie; D T Connelly; D B Northridge; I Ford; J J Morton; H J Dargie; S M Cobbe
Journal:  Br Heart J       Date:  1993-03

10.  Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction.

Authors:  J G Cleland; D Shah; S Krikler; A Dritsas; P Nihoyannopoulos; G Frost; C M Oakley
Journal:  Br Heart J       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.